UFP Technologies rises 17.7% after quarterly results beat estimates

What happened

UFP Technologies (UFPT) rose 17.7% on November 4, 2026, because its third-quarter results topped estimates. The company reported sales of $172.4 million and earnings per share of $2.88, beating the Zacks consensus of $2.63 and reflecting broad demand across its medical technology portfolio, according to the company. Management said it is investing in capacity, operational improvements and acquisitions heading into 2027, and investors responded with heavy buying.

How big was the move

The stock opened 9.4% above the previous close and closed the session up 17.7%, a move that was 6.7 times a typical daily move for this stock. Trading volume was 3.5 times its 20-day average, an indication of unusually strong participation. The gain outpaced the Healthcare sector median, which rose 3.3% on the day, and was 14.4 percentage points better than the sector median. The S&P 500 rose 1.6% on the day while the index fell 0.7% over the prior five sessions, underscoring that the reaction was company-specific.

The technical picture

The stock sat 13.2% above its 50-day moving average and 12.6% above its 20-day moving average, and it finished 3.6% below its 52-week high. It was 32.0% above its 200-day moving average and had spent 108 consecutive trading days above that longer-term level, while the 50-day average is above the 200-day average, a sign of an established uptrend. The 14-day Relative Strength Index was 68, inside a neutral range, and one-month change was a rise of 8.9% while the three-month change rose 5.8%. Volatility was 42% annualized over 60 days, lower than 64% of its own readings over five years, suggesting recent upside came with relatively muted variability compared with the stock’s history.

Fundamentals and valuation

For the four quarters through September 30, 2026, UFP Technologies reported revenue of $649.5 million, which grew 8.6% from a year earlier, and diluted earnings per share of $9.80, which rose 13.6% year over year. Gross margin was 28.9% versus 28.5% a year earlier, while operating margin was 15.5% compared with 15.6% a year earlier. Return on invested capital was 12.7% and the balance sheet showed net debt of 0.7 times EBITDA. Share count over one year increased by 0.3%.

The stock traded at 33.7 times trailing earnings and 33.9 times expected forward earnings, a valuation higher than 81% of its own readings over the past five years; its five-year median was 28.3 times earnings. That premium reflects a combination of solid recent growth and high PromtFinance scores: Momentum was 92 (Exceptional) and Quality was 88 (Strong), while Value was 67 (Positive) and Growth was 70 (Positive). Market value stood at $2.20 billion.

Earnings and analyst expectations

UFP Technologies reported its most recent results on November 3, 2026, with earnings per share of $2.88 against $2.49 expected, 15.7% above estimates. The company has beaten estimates for 12 consecutive quarters and its average surprise over the last four reports was 11.1% above estimates. Typical two-day reactions after recent reports have been a rise of 3.3%, making the 17.7% single-day move on November 4, 2026, unusually large but consistent with the strong beat and management’s comments on demand and investment. Analysts’ consensus price target stood at $298.00, which was 9.6% below the closing price on the session following the report.

What to watch

• Next report: February 23, 2027
• Last report: November 3, 2026: earnings per share of $2.88 against $2.49 expected, 15.7% above estimates
• Trading volume on November 4, 2026: 3.5 times its 20-day average
• Price to trailing earnings: 33.7 times trailing earnings
• Consecutive trading days above the 200-day average: 108